Henry A. Fernandez - 31 Mar 2025 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Sean Weisberg, as Attorney-in-Fact for Henry A. Fernandez
Issuer symbol
RPRX
Transactions as of
31 Mar 2025
Net transactions value
+$37,500
Form type
4
Filing time
01 Apr 2025, 17:45:32 UTC
Previous filing
25 Feb 2025
Next filing
14 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Award $37,500 +1,141 +2.1% $32.87 56,646 31 Mar 2025 Direct F1
holding RPRX Class A Ordinary Shares 58,200 31 Mar 2025 By Fernandez 2007 Children's Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.